CLAD or BOS? : classification and pathogenesis

G. Verleden (Leuven, Belgium)

Source: ERS Course 2016
Number: 21

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Verleden (Leuven, Belgium). CLAD or BOS? : classification and pathogenesis. ERS Course 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The pathogenesis of IPF: what is the latest paradigm?
Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis
Year: 2019

BOS sub-phenotyping: beyond lung function
Source: School Course 2012 - Lung Transplantation
Year: 2012

Bronchiolitis obliterans syndrome: still a valid terminology to reflect chronic rejection?
Source: Annual Congress 2011 - Novelties in lung transplantation
Year: 2011

Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients?
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007

Interstitial pneumonia with autoimmune features: a new classification still on the move
Source: Eur Respir Rev, 27 (148) 180047; 10.1183/16000617.0047-2018
Year: 2018

Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Source: Eur Respir J 2005; 25: 221-224
Year: 2005

Bronchiolitis obliterans syndrome after single lung transplantation: impact of time to onset on functional pattern and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 563s
Year: 2002

COPD: an autoimmune disease?
Source: Eur Respir J 2011; 38: 484
Year: 2011

The obstacle race of post-infectious bronchiolitis obliterans (PIBO): Prognostic factor analysis
Source: International Congress 2016 – Paediatric respiratory infection
Year: 2016

Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure?
Source: Eur Respir J 2011; 37: 10-12
Year: 2011

Pulmonary function and clinical outcome of patients with post-infectious bronchiolitis obliterans (BO)
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007

Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1
Year: 2004

Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema?
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009

Incidence and risk factors for bronchiolitis obliterans syndrome stage 0p after lung transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

Early diagnosis of bronchiolitis obliterans syndrome diagnosis after lung transplantation using functional respiratory imaging (FRI)
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016

Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort.
Source: International Congress 2017 – Novel and old entities
Year: 2017

Introduction: new therapeutic approaches to bronchiolitis obliterans
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005

Bronchiolitis obliterans (BO) in mice lung: a simple model by nasal-drop
Source: Eur Respir J 2005; 26: Suppl. 49, 732s
Year: 2005

A new paradigm for classification of disease severity and progression of COPD
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012

A new biomarker for chronic lung allograft dysfunction
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014